Remission of severe cold agglutinin disease after Rituximab therapy

被引：36

作者：

Layios, N

Van den Neste, E

Jost, E

Deneys, V

Scheiff, JM

Ferrant, A

机构：

[1] Catholic Univ Louvain, Serv Hematol, Clin Univ St Luc, B-1200 Brussels, Belgium

[2] Catholic Univ Louvain, Serv Biol Hematol, Clin Univ St Luc, B-1200 Brussels, Belgium

来源：

LEUKEMIA | 2001年 / 15卷 / 01期

关键词：

D O I：

10.1038/sj.leu.2401976

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：187 / 188

页数：2

共 8 条

[1] The combination of interleukin-2 and interferon α effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29 [J].

Bungard, S ;

Flieger, D ;

Schweitzer, S ;

Sauerbruch, T ;

Spengler, U .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (04) :213-220

[2] Rituximab therapy in Waldenstrom's macroglobulinemia:: Preliminary evidence of clinical activity [J].

Byrd, JC ;

White, CA ;

Link, B ;

Lucas, MS ;

Velasquez, WS ;

Rosenberg, J ;

Grillo-López, AJ .

ANNALS OF ONCOLOGY, 1999, 10 (12) :1525-1527

[3] Rituxan in the treatment of cold agglutinin disease [J].

Lee, EJ ;

Kueck, B .

BLOOD, 1998, 92 (09) :3490-3491

[4] IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab [J].

Levine, TD ;

Pestronk, A .

NEUROLOGY, 1999, 52 (08) :1701-1704

[5]

Maloney DG, 1997, BLOOD, V90, P2188

[6] ALPHA-INTERFERON FOR SEVERE COLD AGGLUTININ DISEASE [J].

OCONNOR, BM ;

CLIFFORD, JS ;

LAWRENCE, WD ;

LOGUE, GL .

ANNALS OF INTERNAL MEDICINE, 1989, 111 (03) :255-256

[7]

Venugopal P, 1998, BLOOD, V92, p247A

[8]

Zaja F, 1999, HAEMATOLOGICA, V84, P1157

← 1 →